Avience Biomedicals IPO
ListedSME
385.32×
Subscribed
Price band
₹208 – ₹208
Issue size
₹30.24 Cr
Open – close
18 Jun 2026
to 22 Jun 2026
Listing
25 Jun 2026
What the filing actually says
Our read of the offer document and the exchange data — not the issuer's summary of itself
Strong3 of 7 dimensions read
The disclosed numbers are strong — 3 of 3 signals read positive
Strength89/100
- Undemanding valuation10.9× earnings at the upper band, with no peer set published to compare against
- High return on equityROE of 49.9%
- Institutions bid heavilyQIB portion subscribed 196.77×
Every line above is arithmetic on a figure shown elsewhere on this page - no model, no opinion. It describes the quality of the offering as disclosed, and is pulled toward neutral to reflect how much the document leaves unsaid. It is not a prediction of the listing price, and it is not advice to apply.
Dates
The issuer's tentative timetable — a date passing is not confirmation the step completed
- Opens18 Jun 2026
- Closes22 Jun 2026
- Listing25 Jun 2026
Demand and your odds
How the book filled, and what that means for an application
Subscription by category
Qualified institutionalQIB196.77x
Non-institutionalNII / HNI597.23x
Big NIIabove ₹10L670.18x
Small NII₹2L – ₹10L451.35x
Retail individualRII401.36x
1,92,952 applications received — how many people bid, as opposed to how much money did. Exchange figures as of 22 Jun 2026.
Chance of allotment
Retail401.36× subscribed
~1 in 401.4
Retail is 401.36× subscribed. Allotment is a lottery on a single lot, so roughly 1 in 401.4 applications gets one lot. Bidding for extra lots does not improve these odds.
HNI / NII597.23× subscribed
~1 in 597.2
HNI is 597.23× subscribed. This category is allotted proportionately, so a bid receives roughly 1/597.2 of the shares applied for, subject to the minimum-lot draw.
Derived from SEBI's allotment mechanics and the subscription figures beside it. Retail allotment is a lottery on a single lot, so applying for more lots does not improve your chance of getting something.
Grey market premium
Unofficial dealer quotes — not published by NSE, BSE, SEBI or the company
₹70+33.7%
over the upper band · last seen 07 Sept 2026
What this number is not. Grey-market premium is an unregulated, thinly-traded quote from private dealers. It is not a forecast of the listing price, it is not verifiable, and it can be moved by the same people who benefit from it looking high. We publish it because you will look it up anyway — and we deliberately do not convert it into an expected listing gain, because that arithmetic implies a reliability the number has never earned. For what actually happened to comparable issues, see recent outcomes below.
The offering
Terms, structure and who is selling
Terms
Price band₹208 – ₹208
Total issue size₹30.24 Cr
Listing atSME platform
Company & valuation
P/E at upper band10.91×
EPS₹19.06pre-issue
NAV per share₹56.50
Return on equity49.89%
EBITDA margin25.22%
ROCE16.99%
Debt/Equity0.94
RoNW22.38%
EBITDA Margin24.70%
NAV70.74
Price to Book Value2.94
ISININE0V9I01017
RegistrarSKYLINE FINANCIAL SERVICES PRIVATE LIMITED
Lead managersFINTELLECTUAL CORPORATE ADVISORS PRIVATE LIMITED
Who gets what
How the issue is split between investor categories, and what each may bid.
| Category | Shares | % of issue |
|---|---|---|
| QIB Shares Offered | 6,83,400 | 47.01% |
| Anchor Investor Shares Offered | 4,09,800 | 28.19% |
| QIB (Ex. Anchor) Shares Offered | 2,73,600 | 18.82% |
| NII (HNI) Shares Offered | 2,07,000 | 14.24% |
| bNII > ₹10L | 1,38,000 | 9.49% |
| sNII < ₹10L | 69,000 | 4.75% |
| Retail Shares Offered | 4,81,200 | 33.10% |
| Market Maker Shares Offered | 82,200 | 5.65% |
Total issue 14,53,800 shares. Indented rows sit inside the category above them and are not added to it.
What each category may bid
Individual investors (IND) (Min)₹2,49,6002 lots · 1,200 sh
Individual investors (IND) (Max)₹2,49,6002 lots · 1,200 sh
S-HNI (Min)₹3,74,4003 lots · 1,800 sh
S-HNI (Max)₹9,98,4008 lots · 4,800 sh
B-HNI (Min)₹11,23,2009 lots · 5,400 sh
Lot size alone does not answer "how much do I need" — an S-HNI minimum is several lots, not one.
Anchor book
Shares allotted4,09,800
Anchor portion₹8.52 Cr
Bid date17 Jun 2026
Lock-in ends (50%)23 Jul 2026
Lock-in ends (rest)21 Sept 2026
Anchors are institutional money placed a day before bidding opens, against a lock-in. Those two dates are when that stock can first be sold — a supply event worth knowing if you still hold.
What the money is for
Stated use of the net proceeds
- 01Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh₹14.05 Cr
- 02Funding the working capital requirement of our Company₹8.25 Cr
- 03General Corporate Purposes₹3.97 Cr
What happened to comparable issues
The last 8 issues to list with a recorded opening price, most comparable first
Median listing gain
-2.2%
Listed up
1 of 8
Best
+0.4%
Papadmalji Agro Foods Limited
Worst
-17.5%
Himalayan Solar
Ravita Engineering Services Limitedsame segment
6.7× sub+0.0%
Vaibhav Vyapaar Limitedsame segment
3.1× sub-2.0%
R.K. Fashion Accessories Limitedsame segment
2.6× sub-2.4%
Eventions Limitedsame segment
2.3× sub-5.9%
Green Asia Impexsame segment
1.0× sub+0.0%
Papadmalji Agro Foods Limitedsame segment
2.5× sub+0.4%
Dudani Retailsame segment
1.4× sub-13.8%
Himalayan Solarsame segment
1.2× sub-17.5%
Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.
Offer documents
The primary sources everything above is drawn from
Common questions
What is the Avience Biomedicals IPO GMP today?
The most recent grey-market premium recorded for Avience Biomedicals is ₹70 per share — about 33.7% over the ₹208 upper band. Grey-market premium is an unofficial, unregulated quote from private dealers. It is not published by NSE, BSE, SEBI or the company, and it is not a forecast of the listing price.
How many times is the Avience Biomedicals IPO subscribed?
Avience Biomedicals is subscribed 385.32× overall (QIB 196.77×, NII 597.23×, retail 401.36×). Subscription keeps changing until the issue closes; the final basis of allotment is published by the registrar, SKYLINE FINANCIAL SERVICES PRIVATE LIMITED.
What are the chances of allotment in the Avience Biomedicals IPO?
The retail portion is subscribed 401.36×, so allotment is by lottery and the odds of receiving at least one lot are roughly 1 in 401. Applying for more lots does not improve the chance of getting something — every retail applicant competes for the same single minimum lot.
Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.